Femasys Inc (FEMY): R&D Expense
$7.58M
Year ended 2025-12-31
$6.45M
Trailing 12 months to 2026-06-30
+9.2%
3-year compound annual growth
+12.9%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.58M | -7.8% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $8.22M | +14.0% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $7.21M | +24.0% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $5.81M | +42.3% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $4.08M | -1.1% | 2023-07-24, From 2021-01-01 |
| 2020-12-31 | $4.13M | n/a | 2022-03-24, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Femasys Inc (FEMY) | 2025-12-31 | $7.58M | -7.8% |
| QHSLab, Inc. (USAQ) | 2025-12-31 | $484.9K | +64.7% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| OSR Health, Inc. (OSRH) | 2025-12-31 | $318.4K | +97.6% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| IceCure Medical Ltd. (ICCM) | 2025-12-31 | $7.43M | +4.7% |
| Tenon Medical, Inc. (TNON) | 2025-12-31 | $2.15M | -17.4% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
Compare FEMY, USAQ, VYCO, OSRH side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗